Bioactive Constituents from Asparagus cochinchinensis
⊥
Hong-Jie Zhang,
†
Kongmany Sydara,
‡
Ghee Teng Tan,
†
Cuiying Ma,
†
Bounhoong Southavong,
‡
D. Doel Soejarto,
†
John M. Pezzuto,
†,§
and Harry H. S. Fong*
,†
Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and
Pharmacognosy (M/C877), College of Pharmacy, the University of Illinois at Chicago, 833 S. Wood Street,
Chicago, Illinois 60612, and Traditional Medicine Research Center (TMRC), Ministry of Health,
Vientiane, Laos, People’s Democratic Republic
Received August 10, 2003
Bioassay-directed fractionation of the dried roots of Asparagus cochinchinensis led to the isolation of a
new spirostanol saponin, asparacoside (1), two new C-27 spirosteroids, asparacosins A (2) and B (3), a
new acetylenic derivative, 3′′-methoxyasparenydiol (4), and a new polyphenol, 3′-hydroxy-4′-methoxy-4′-
dehydroxynyasol (6), as well as five known phenolic compounds, asparenydiol (5), nyasol (7), 3′′-
methoxynyasol (8), 1,3-bis-di-p-hydroxyphenyl-4-penten-1-one (9), and trans-coniferyl alcohol (10).
Compounds 1, 6, and 8 demonstrated moderate cytotoxicities in a panel comprised of KB, Col-2, LNCaP,
Lu-1, and HUVEC cells, with IC
50
values ranging from 4 to 12 µg/mL. The structures were determined
by spectroscopic and chemical methods.
The dried roots of Asparagus cochinchinensis (Lourerio)
Merrill (Asparagaceae) are used in Laos to treat chronic
fever [Lao name of plant: Kheua Ya Nang Xang; voucher
specimen K.Sydara037]. The plant also has a long history
of use for treating fever, cough, kidney diseases, and benign
breast tumors in China.
1
Phytochemically, they have been
reported to contain monosaccharides, oligosaccharides,
2
polysaccharides,
3
furostanol oligosides,
4
and phenolic com-
pounds.
5
As part of an International Cooperative Bio-
diversity Group (ICBG) involving the collaboration of
institutions in Vietnam, Laos, and the United States,
6
a
MeOH extract prepared from the roots of A. cochinchinensis
collected in Laos was shown initially to inhibit HIV-1
replication by 78% at 20 µg/mL, while being devoid of
cytoxicity in the HOG.R5 cell line. Dried roots (5 kg) of this
plant were, therefore, re-collected for bioassay-directed
fractionation studies aimed at identifying novel anti-HIV
constituents. However, as the anti-HIV bioassay-directed
fractionation proceeded, cytotoxic fractions emerged. With
each level of separation, the cytotoxicity of concentrated
fractions increased, which led us to redirect our efforts
toward the isolation of potential antitumor compounds. As
a result, six cytotoxic compounds were isolated from the
roots of A. cochinchinensis. The current paper describes the
isolation, structure elucidation, and biological evaluation
of the compounds isolated from this plant.
Results and Discussion
Separation of the CHCl
3
-soluble fraction of the MeOH
extract of the dried roots of A. cochinchinensis utilizing
parallel HIV-infectivity and toxicity assays in the HOG.R5
reporter cell line
7
led to the isolation of a new spirostanol
saponin, asparacoside (1), two new C-27 spirosteroids,
asparacosins A (2) and B (3), a new acetylenic derivative,
3′′-methoxyasparenydiol (4), and a new polyphenol, 3′-
hydroxy-4′-methoxy-4′-dehydroxynyasol (6). In addition,
the known compounds asparenydiol (5),
8
nyasol (7),
9
3′′-
methoxynyasol (8),
10
1,3-bis-di-p-hydroxyphenyl-4-penten-
1-one (9),
11
and trans-coniferyl alcohol (10) were also
obtained.
12
Asparacoside (1) was obtained as a white powder with a
molecular formula of C
49
H
80
O
21
based on HRTOFMS and
NMR (Tables 1-4) studies. Anomeric signals of four sugar
units were observed in the
1
H and
13
C NMR spectra of 1
[δ
H
5.38 (d, J ) 7.7 Hz), 5.30 (d, J ) 7.7 Hz), 5.01 (d, J )
7.4 Hz), 4.74 (d, J ) 7.7 Hz) and δ
C
105.7 (d), 105.3 (d),
105.2 (d), 101.4 (d)] (Tables 3 and 4). The aglycone of 1
was determined to be a spirostanol by comparison of its
NMR data (Tables 1 and 2) with those of known spirostane-
type steroids
13
and was identified as sarsasapogenin due
to its NMR data being identical to those reported in the
literature.
14,15
A partial acid hydrolysis of 1 afforded a
mixture containing sarsasapogenin glycosides 1a-d, which
were separated by preparative HPLC chromatography.
Compound 1a contains a disaccharide group [δ
H
5.40 (d, J
) 7.7 Hz), 4.96 (d, J ) 7.6 Hz) and δ
C
106.0 (d), 102.0 (d)],
which was determined to be a [-D-glucopyranosyl-(1f2)]-
-D-glucopyranosyl unit according to 1D and 2D NMR
spectral data (Tables 3 and 4) including HMBC. The
disaccharide unit attached to the C-3 of the sarsasapogenin
aglycone was determined by the presence of the HMBC
correlation between the anomeric proton signal at δ
H
4.96
and the signal at δ
C
75.2 (d). Compound 1a was identified
as 25(S)-5-spirostan-3-ol 3-O--D-glucopyranosyl-(1f2)-
-D-glucopyranoside, a component of a mixture of spirostanol
saponins, known as 25S-schidigerasaponin D5, which was
originally reported as a 25S/25R mixture from the stems
of Yucca schdigera.
15
Compounds 1b-d were elucidated as
sarsasaponenin trisaccharides due to their characteristic
sugar anomeric signals observed in the
1
H and
13
C NMR
spectra (Tables 3 and 4). In addition to the glucopyranosyl-
(1f2)]--D-glucopyranosyl unit, an additional sugar unit
was revealed in the NMR spectra for both 1b and 1d. The
additional sugar unit in both compounds was identified as
R-L-arabinopyranosyl through analysis of the NMR spectral
data. The R-L-arabinopyranosyl unit of 1b was connected
to C-4′ of the inner -D-glucopyranosyl unit based on the
presence of a HMBC correlation between the R-L-ara-
binopyranosyl anomeric proton signal at δ
H
4.98 and the
C-4′ NMR signal at δ
C
81.4 (d), which resulted in a
⊥
Dedicated to the late Dr. Monroe E. Wall and to Dr. Mansukh C. Wani
of Research Triangle Institute for their pioneering work on bioactive natural
products.
* To whom correspondence should be addressed. Tel: (312) 996-5972.
Fax: (312) 413-5894. E-mail: hfong@uic.edu.
†
Program for Collaborative Research in the Pharmaceutical Sciences.
‡
Traditional Medicine Research Center.
§
Current address: Schools of Pharmacy, Nursing, and Health Sciences,
Purdue University, 575 Stadium Mall Dr., West Lafayette, IN 47907-2091.
10.1021/np030370b CCC: $27.50 © 2004 American Chemical Society and American Society of Pharmacognosy
Published on Web 01/21/2004